Millendo Therapeutics Inc. (MLND) to Offer Common Stock

Millendo Therapeutics, Inc. (Nasdaq: MLND) announced that it has commenced an underwritten public offering of shares of its common stock. Millendo also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering. All of the shares are being offered by Millendo.

Citigroup and SVB Leerink are acting as joint book-running managers for the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

The shares are being offered by Millendo pursuant to an effective shelf registration statement that was filed with the Securities and Exchange Commission (SEC) on April 5, 2019 and declared effective by the SEC on April 18, 2019.

You May Also Be Interested In

• Kayne Anderson closes $15M preferred share private placement
• Accendra Health receives NYSE noncompliance notice over market cap
• Repligen prices $1B convertible notes due 2031 to refinance 2028 debt